Olema Shelf Registration Raises Questions On Dilution And Funding Flexibility [Yahoo! Finance]
Olema Pharmaceuticals, Inc. (OLMA)
Company Research
Source: Yahoo! Finance
Olema Pharmaceuticals (NasdaqGS:OLMA) has filed a significant shelf registration that would allow it to issue additional securities. The filing creates a framework for potential future capital raising or funding transactions. The move represents a material corporate step that could influence Olema's financial flexibility and deal making options. Olema focuses on oncology drug development, so access to capital is a core part of how it funds clinical programs and related research. The new shelf registration gives the company a mechanism to tap markets if it decides conditions are suitable, whether for trials, partnerships, or other corporate purposes. For you as an investor, this type of filing is worth watching because it can affect both funding plans and potential share issuance over time. Upcoming disclosures around how and when Olema chooses to use this shelf, if at all, may help clarify management's priorities and appetite for new projects or transactions. Stay updated o
Show less
Read more
Impact Snapshot
Event Time:
OLMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OLMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OLMA alerts
High impacting Olema Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
OLMA
News
- Jim Cramer on Olema Pharmaceuticals: “Too Risky for Me” [Yahoo! Finance]Yahoo! Finance
- Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? [Yahoo! Finance]Yahoo! Finance
- Olema Pharmaceuticals (OLMA) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.MarketBeat
- Olema Pharmaceuticals (OLMA) had its price target raised by JPMorgan Chase & Co. from $55.00 to $58.00. They now have an "overweight" rating on the stock.MarketBeat
- Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]Yahoo! Finance
OLMA
Earnings
- 3/16/26 - Beat
OLMA
Sec Filings
- 3/20/26 - Form SCHEDULE
- 3/16/26 - Form 144
- 3/16/26 - Form 144
- OLMA's page on the SEC website